International Gemmological Institute (India) Ltd Rs. 4,225 Crore Initial Public Offering to Open on 13th December 2024
9th December 2024
The International Gemmological Institute (India) Limited (IGI) is set to launch its Rs. 4,225 crore Initial Public Offering (IPO) on December 13, 2024, with a price band of Rs. 397 to Rs 417 per equity share. The IPO comprises a fresh issue and an offer for sale, with the proceeds to be used for the acquisition of IGI Belgium and IGI Netherlands, as well as for general corporate purposes. Leading the offer are Book Running Lead Managers Axis Capital, Kotak Mahindra Capital, Morgan Stanley, and SBI Capital Markets.
- Price Band fixed at Rs. 397 to Rs 417 per equity share of face value of Rs. 2 each (“Equity Shares”)
- Bid /Issue Opening Date – Friday, December 13, 2024 and Bid/Issue Closing Date – Tuesday, December 17, 2024
- Bids can be made for a minimum of 35 Equity Shares and in multiples of 35 Equity Shares thereafter
- A discount of Rs. 39.7 – Rs. 41.7 per Equity Share is being offered to Eligible Employees bidding in the Employee Reservation Portion
- RHP Link: Click here
International Gemmological Institute (India) Limited (“IGI” or “The Company”), shall open its Bid/Offer in relation to its initial public offer of Equity Shares on Friday, December 13, 2024.
Total Offer Size: The total offer size of equity shares (face value of Rs. 2 each) aggregating up to Rs. 42,250 million [Rs. 4,225 crore] comprises a Fresh Issue of aggregating up to Rs. 14,750 million [Rs. 1,475 crore] and Offer for Sale of equity shares aggregating up to Rs. 27,500 million [Rs. 2,750 crore]. (“Total Offer Size”).
Price Band of the issue: Price Band of the issue is fixed at Rs. 397 to Rs 417 per equity share. (“The Price Band”).
Employee Reservation Portion Discount: The price band includes a discount of Rs. 39.7 – Rs. 41.7 per Equity Share is being offered to Eligible Employees bidding in the Employee Reservation Portion (“Employee Reservation Portion Discount”). Bids can be made for a minimum of 35 Equity Shares and in multiples of 35 Equity Shares thereafter. (“Bid Lot”).
Object of the Offer:
Utilization of the Net Proceeds: The Company proposes to utilize the Net Proceeds towards funding the following objects – Payment of the purchase consideration for the acquisition of IGI Belgium Group and IGI Netherlands Group from Promoter estimated to Rs. 13,000 million [Rs. 1,300 crore]; and the balance amount towards General corporate purpose. (“Object of the Offer”)
Offer for Sale:
Offer for Sale: The offer for sale comprises of equity shares aggregating up to Rs. 27,500 million [Rs. 2,750 crore] by BCP Asia II TopCo Pte. Ltd. (“Promoter Selling Shareholder”)
Red Herring Prospectus:
RHP Filing: The Equity Shares are being offered through the Red Herring Prospectus of the Company dated December 06, 2024; filed with the Registrar of Companies Maharashtra, Mumbai. (“ROC”)
Statements from Key Stakeholders:
Amit Dixit, Head of Private Equity Asia, Blackstone: “We are incredibly proud to support IGI on this next chapter of growth. This marks a continuation of our business builder efforts to strengthen IGI’s presence and operations by helping the company expand its reach and offerings and become a one-stop provider of certification. When we first invested in the company two years ago, we knew it had tremendous potential under Tehmasp’s stewardship with the right resources and access. We will continue to partner with the management team and remain heavily invested in IGI, cementing its market leading position.”
Tehmasp Printer, Managing Director and Chief Executive Officer, IGI: “This is a tremendous milestone for IGI. From Inception, our vision is to grow this business into global leadership. We have been the first movers in India. We have demonstrated strong expertise & innovation in an industry with enormous potential for growth. We are here with the backing of Blackstone and excited to take the 50 year old global company public in India”
Mukesh Mehta, Senior Managing Director, Blackstone: “This is a remarkable achievement for IGI and couldn’t have come at a better time. In less than two years, we have helped solidify IGI’s position as a global leader in the certification of lab grown diamonds and an increasingly competitive player in other segments. We remain the largest shareholder at IGI and are thrilled to continue to partner with IGI in its next phase of growth.”
Offer Allocation:
- QIB Portion:
The Offer is being made through the Book Building Process, in terms of Rule 19(2)(b) of the SCRR read with Regulation 31 of the SEBI ICDR Regulations and in compliance with Regulation 6(2) of the SEBI ICDR Regulations, wherein not less than 75% of the Net Offer shall be allocated on a proportionate basis to Qualified Institutional Buyers (“QIBs”) (“QIB Portion”), provided that our Company may, in consultation with the Book Running Lead Managers, allocate up to 60% of the QIB Portion to Anchor Investors on a discretionary basis in accordance with the SEBI ICDR Regulations (“Anchor Investor Portion”), of which one-third shall be reserved for domestic Mutual Funds, subject to valid Bids being received from domestic Mutual Funds at or above the Anchor Investor Allocation Price. In the event of under-subscription, or non-allocation in the Anchor Investor Portion, the balance Equity Shares shall be added to the QIB Portion (“Net QIB Portion”).
- Mutual Funds Portion:
Further, 5% of the Net QIB Portion shall be available for allocation on a proportionate basis only to Mutual Funds, subject to valid Bids being received at or above the Offer Price, and the remainder of the Net QIB Portion shall be available for allocation on a proportionate basis to all QIBs, including Mutual Funds subject to valid Bids being received at or above the Offer Price. However, if the aggregate demand from Mutual Funds is less than 5% of the Net QIB Portion, the balance Equity Shares available for allocation in the Mutual Fund Portion will be added to the remaining Net QIB Portion for proportionate allocation to all QIBs.
Non-Institutional Portion:
Further, not more than 15% of the Net Offer shall be available for allocation to Non-Institutional Bidders and not more than 10% of the Net Offer shall be available for allocation to Retail Individual Bidders in accordance with the SEBI ICDR Regulations, subject to valid Bids being received at or above the Offer Price. One-third of the Non-Institutional Portion shall be available for allocation to Non-Institutional Bidders with a Bid size of more than Rs. Rs. 0.20 million and up to Rs. 1.00 million and two-thirds of the Non-Institutional Portion shall be available for allocation to Non-Institutional Bidders with a Bid size of more than Rs. 1.00 million provided that under-subscription in either of these two sub-categories of the Non-Institutional Portion may be allocated to Non-Institutional Bidders in the other sub-category of Non-Institutional Portion in accordance with the SEBI ICDR Regulations, subject to valid Bids being received at or above the Offer Price.
- Employee Reservation Portion:
Further, Equity Shares will be allocated on a proportionate basis to Eligible Employees Bidding in the Employee Reservation Portion, subject to valid Bids received from them at or above the Offer Price.
ASBA Process:
- Application Supported by Blocked Amount:
All potential Bidders (except Anchor Investors) are mandatorily required to participate in the Offer through the Application Supported by Blocked Amount (“ASBA”) process by providing details of their respective ASBA accounts and UPI ID in case of UPI Bidders, as applicable, pursuant to which their corresponding Bid Amount will be blocked by the SCSBs or by the Sponsor Bank(s) under the UPI Mechanism, as the case may be, to the extent of the respective Bid Amounts. Anchor Investors are not permitted to participate in the Offer through the ASBA process. For details, see “Offer Procedure” on page 569.
Book Running Lead Managers:
- Axis Capital Limited
- Kotak Mahindra Capital Company Limited
- Morgan Stanley India Company Private Limited
- SBI Capital Markets Limited
All capitalized terms used herein but not defined shall have the same meaning as ascribed to them in the RHP.
